Primary Site >> Liver Cancer
Gene >> CYR61
| 1. | |||||||||||
| Journal: | Hepatol Res. 2001 Mar 26;19(3):294-305. | ||||||||||
| Title: | Expression of Nov, CYR61 and CTGF genes in human hepatocellular carcinoma. | ||||||||||
| Author: | Hirasaki, S|Koide, N|Ujike, K|Shinji, T|Tsuji, T | ||||||||||
| PMID: | 11251312 | ||||||||||
| 2. | |||||||||||
| Journal: | World J Gastroenterol. 2004 Dec 1;10(23):3414-8. | ||||||||||
| Title: | Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance. | ||||||||||
| Author: | Zeng, Zhi-Jun|Yang, Lian-Yue|Ding, Xiang|Wang, Wei | ||||||||||
| PMID: | 15526358 | ||||||||||
| 3. | |||||||||||
| Journal: | Ann N Y Acad Sci. 2004 Dec;1028:432-9. | ||||||||||
| Title: | Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. | ||||||||||
| Author: | Cervello, Melchiorre|Giannitrapani, Lydia|Labbozzetta, Manuela|Notarbartolo, Monica|D'Alessandro, Natale|Lampiasi, Nadia|Azzolina, Antonina|Montalto, Giuseppe | ||||||||||
| PMID: | 15650268 | ||||||||||
| 4. | |||||||||||
| Journal: | Oncogene. 2005 Jun 2;24(24):3999-4008. | ||||||||||
| Title: | Dinucleotide repeats negatively modulate the promoter activity of Cyr61 and is unstable in hepatocellular carcinoma patients. | ||||||||||
| Author: | Wang, Baoshuang|Ren, Jianwei|Ooi, London L P J|Chong, Samuel S|Lee, Caroline G L | ||||||||||
| PMID: | 15782120 | ||||||||||
| 5. | |||||||||||
| Journal: | Int J Biochem Cell Biol. 2008;40(1):98-109. | ||||||||||
| Title: | Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response. | ||||||||||
| Author: | Feng, Ping|Wang, Bei|Ren, Ee Chee | ||||||||||
| PMID: | 17698398 | ||||||||||
| 6. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2010 Feb 19;392(4):473-8. | ||||||||||
| Title: | Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells. | ||||||||||
| Author: | Hsu, Chin-Mu|Hsu, Yu-An|Tsai, Yuhsin|Shieh, Fa-Kuen|Huang, Su-Hua|Wan, Lei|Tsai, Fuu-Jen | ||||||||||
| PMID: | 19895793 | ||||||||||
| 7. | |||||||||||
| Journal: | Mol Carcinog. 2010 Oct;49(10):882-91. | ||||||||||
| Title: | Differential expression of Axl in hepatocellular carcinoma and correlation with tumor lymphatic metastasis. | ||||||||||
| Author: | He, Ling|Zhang, Jianing|Jiang, Lili|Jin, Changgong|Zhao, Yongfu|Yang, Guang|Jia, Li | ||||||||||
| PMID: | 20635370 | ||||||||||
| 8. | |||||||||||
| Journal: | PLoS One. 2012;7(4):e35754. | ||||||||||
| Title: | Cyr61/CCN1 is regulated by Wnt/beta-catenin signaling and plays an important role in the progression of hepatocellular carcinoma. | ||||||||||
| Author: | Li, Zhi-Qiang|Ding, Wei|Sun, Shi-Jun|Li, Jun|Pan, Jing|Zhao, Chen|Wu, Wei-Ru|Si, Wei-Ke | ||||||||||
| PMID: | 22540002 | ||||||||||
| 9. | |||||||||||
| Journal: | Exp Eye Res. 2014 Jul;124:67-73. | ||||||||||
| Title: | The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation. | ||||||||||
| Author: | Brodowska, Katarzyna|Al-Moujahed, Ahmad|Marmalidou, Anna|Meyer Zu Horste, Melissa|Cichy, Joanna|Miller, Joan W|Gragoudas, Evangelos|Vavvas, Demetrios G | ||||||||||
| PMID: | 24837142 | ||||||||||
| 10. | |||||||||||
| Journal: | Oncol Rep. 2015 Mar;33(3):1481-92. | ||||||||||
| Title: | Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma. | ||||||||||
| Author: | Zhang, Heyun|Li, Wenbin|Huang, Pinbo|Lin, Lehang|Ye, Hua|Lin, Dechen|Koeffler, H Phillip|Wang, Jie|Yin, Dong | ||||||||||
| PMID: | 25571929 | ||||||||||
| 11. | |||||||||||
| Journal: | Oncogene. 2016 Mar 10;35(10):1314-23. | ||||||||||
| Title: | The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation. | ||||||||||
| Author: | Chen, C-C|Kim, K-H|Lau, L F | ||||||||||
| PMID: | 26028023 | ||||||||||
| 12. | |||||||||||
| Journal: | Sci Rep. 2016 Sep 8;6:30238. | ||||||||||
| Title: | YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma. | ||||||||||
| Author: | LaQuaglia, Michael J|Grijalva, James L|Mueller, Kaly A|Perez-Atayde, Antonio R|Kim, Heung Bae|Sadri-Vakili, Ghazaleh|Vakili, Khashayar | ||||||||||
| PMID: | 27605415 | ||||||||||
| 13. | |||||||||||
| Journal: | Int J Mol Med. 2018 Mar;41(3):1518-1528. | ||||||||||
| Title: | CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma. | ||||||||||
| Author: | Li, Zhi-Qiang|Wu, Wei-Ru|Zhao, Chen|Zhao, Chen|Zhang, Xiao-Li|Yang, Zhong|Pan, Jing|Si, Wei-Ke | ||||||||||
| PMID: | 29286082 | ||||||||||
| 14. | |||||||||||
| Journal: | Cell Death Dis. 2018 Feb 15;9(3):269. | ||||||||||
| Title: | EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy. | ||||||||||
| Author: | Xia, Hongwei|Dai, Xinyu|Yu, Huangfei|Zhou, Sheng|Fan, Zhenghai|Wei, Guoqing|Tang, Qiulin|Gong, Qiyong|Bi, Feng | ||||||||||
| PMID: | 29449645 | ||||||||||
| 15. | |||||||||||
| Journal: | J Exp Clin Cancer Res. 2018 Jul 24;37(1):165. | ||||||||||
| Title: | Ajuba inhibits hepatocellular carcinoma cell growth via targeting of beta-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation. | ||||||||||
| Author: | Liu, Min|Jiang, Ke|Lin, Guibin|Liu, Peng|Yan, Yumei|Ye, Tian|Yao, Gang|Barr, Martin P|Liang, Dapeng|Wang, Yang|Gong, Peng|Meng, Songshu|Piao, Haozhe | ||||||||||
| PMID: | 30041665 | ||||||||||
| 16. | |||||||||||
| Journal: | J Exp Clin Cancer Res. 2018 Oct 30;37(1):263. | ||||||||||
| Title: | ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression. | ||||||||||
| Author: | Chen, Cong|Ge, Chao|Liu, Zheng|Li, Liangyu|Zhao, Fangyu|Tian, Hua|Chen, Taoyang|Li, Hong|Yao, Ming|Li, Jinjun | ||||||||||
| PMID: | 30376856 | ||||||||||